Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function

Overview of attention for article published in Journal of Neuro-Oncology, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet

twitter: 9 X users

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 51 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 30,227 followers.

Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function. https://t.co/ki5Vpc9mUV

18 Apr 2020

Reply Repost Favourite

RT @JNeurooncol: Caruso et al @MDAndersonNews have developed a rapid, superior method for CAR-T cell generation and describe the importance…

10 Nov 2019

Reply Repost Favourite

RT @JNeurooncol: Caruso et al @MDAndersonNews have developed a rapid, superior method for CAR-T cell generation and describe the importance…

10 Nov 2019

Reply Repost Favourite

Top story: Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function | SpringerLink https://t.co/fp7bEbVpru, see more https://t.co/rb2MBv6zsm

09 Nov 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.